Global Plasma Therapy Market Size By Type (Pure PRP, Leucocyte-rich PRP), By Application (Orthopedic, Darmatology), By Region, And Segment Forecasts, 2023 to 2032

The Global Plasma Therapy Market was valued at USD 304.7 million in 2023 and is projected to reach USD 672.5 million by 2031, expanding at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2031. Plasma therapy, particularly Platelet-Rich Plasma (PRP) and Convalescent Plasma Therapy, is gaining widespread acceptance across regenerative medicine, orthopedics, dermatology, and infectious disease treatments. The demand for non-invasive, personalized treatments and the increasing prevalence of chronic diseases are key factors propelling the market growth.

Drivers:

1. Rising Demand for Regenerative Medicine:

Plasma therapy is widely utilized for tissue repair and regeneration in orthopedics and sports medicine. The growing emphasis on natural healing methods and tissue repair is accelerating adoption.

2. Increasing Incidence of Chronic Diseases and Musculoskeletal Disorders:

With aging populations globally and rising physical activity levels, there’s a surge in conditions like osteoarthritis, tendonitis, and chronic pain, which are effectively managed by PRP therapy.

3. Advancements in Plasma Extraction Techniques:

Innovations in centrifugation and plasma separation technologies have improved therapy outcomes, reduced contamination risk, and enhanced patient safety, boosting clinical adoption.

Restraints:

1. Lack of Standardized Treatment Protocols:

Variability in plasma preparation, dosage, and administration methods has led to inconsistent clinical outcomes, limiting widespread adoption.

2. Limited Insurance Reimbursement:

Plasma therapies are often categorized as experimental or elective procedures, and lack of reimbursement poses a challenge, especially in cost-sensitive regions.

Opportunity:

1. Expanding Applications in Dermatology and Aesthetic Medicine:

Growing consumer interest in anti-aging solutions and scar reduction treatments is creating demand for PRP-based cosmetic therapies.

2. Integration with Stem Cell Therapies:

Combining plasma therapy with stem cell research opens up new treatment frontiers, particularly for neurodegenerative and cardiovascular diseases.

3. Emerging Markets and Medical Tourism:

Countries in Asia-Pacific and Latin America are investing heavily in healthcare infrastructure, presenting untapped potential for plasma therapy applications, especially in aesthetic and orthopedic procedures.

Market by System Type Insights:

The Platelet-Rich Plasma (PRP) segment dominated the market in 2023 and is expected to continue leading during the forecast period. PRP is highly preferred due to its ability to stimulate natural healing with minimal side effects, making it the go-to choice in sports medicine and aesthetics.

Convalescent Plasma Therapy, primarily used during infectious disease outbreaks such as COVID-19, remains a critical backup treatment but is more episodic in use compared to PRP.

Market by End-use Insights:

Hospitals & Clinics represented the largest share in 2023, owing to increasing in-patient treatments and the growing number of specialized departments offering plasma therapies.

The cosmetic & dermatology centers segment is expected to witness the fastest growth, driven by rising consumer demand for non-surgical aesthetic enhancements.

Market by Regional Insights:

North America led the global plasma therapy market in 2023, supported by advanced healthcare infrastructure, favorable regulatory policies, and a high adoption rate of regenerative treatments.

Asia-Pacific is forecast to register the highest CAGR during the period 2023–2031. Countries like India, China, and South Korea are emerging as key hubs due to medical tourism, cost-effective treatment offerings, and growing awareness of plasma therapies.

Competitive Scenario:

Key players in the Global Plasma Therapy Market include Zimmer Biomet, Terumo BCT Inc., Arthrex Inc., EmCyte Corporation, BioLife Plasma Services, CSL Behring, Octapharma, Grifols S.A., and Kedrion S.p.A. These companies are investing in R&D, launching advanced plasma kits, and entering strategic collaborations to broaden their market presence.

Recent Developments:

In 2023, Zimmer Biomet introduced an advanced PRP system with improved centrifugation technology for enhanced platelet concentration.

In 2024, Arthrex expanded its PRP device portfolio in Europe, targeting sports injury clinics and orthopedic practices.

Grifols S.A. announced in 2025 a new initiative to enhance plasma collection capabilities across Latin America, focusing on convalescent plasma research.

Scope of Work – Global Plasma Therapy Market

Report Metric Details

Market Size (2023) USD 304.7 million

Projected Market Size (2031) USD 672.5 million

CAGR (2023–2031) 10.2%

Market Segments By System Type (PRP, Convalescent Plasma), By End-use (Hospitals & Clinics, Dermatology Centers, Research Institutes), By Region

Growth Drivers Increasing demand for regenerative therapies, rising chronic disease burden, and technological advancements

Opportunities Aesthetic medicine growth, emerging market expansion, stem cell integration

Key Market Developments:

Zimmer Biomet (2023): Launched next-gen PRP kit with advanced concentration techniques.

Arthrex (2024): Expanded plasma therapy portfolio across Europe for outpatient clinics.

Grifols S.A. (2025): Scaled convalescent plasma operations in Latin America to support pandemic preparedness.

FAQs:

1) What is the current market size of the Global Plasma Therapy Market?

The Global Plasma Therapy Market was valued at USD 304.7 million in 2023.

2) What is the major growth driver of the Global Plasma Therapy Market?

The increasing demand for regenerative medicine and rising prevalence of musculoskeletal disorders are major growth drivers.

3) Which is the largest region during the forecast period in the Global Plasma Therapy Market?

North America is expected to dominate due to advanced healthcare infrastructure and high procedural volumes.

4) Which segment accounted for the largest market share in the Global Plasma Therapy Market?

The Platelet-Rich Plasma (PRP) segment held the largest share in 2023.

5) Who are the key market players in the Global Plasma Therapy Market?

Leading players include Zimmer Biomet, Terumo BCT Inc., Arthrex Inc., EmCyte Corporation, and Grifols S.A.